DARE
Dare Bioscience, Inc. (DARE) Risks & Opportunities Analysis (2026)
No material changes this month.
Risks
Near-term liquidity is tight with a current ratio just below 1.0, leaving DARE less cushion than larger peers if working-capital needs rise or funding markets tighten.
Negative interest coverage indicates earnings are not covering financing costs, so any revenue softness could pressure cash generation more than at profitable peers.
A highly negative cash conversion cycle reflects heavy supplier financing, which can support operations but also increases dependence on counterparties versus peers with stronger self-funding.
Net leverage is manageable on a net-debt-to-EBITDA basis, yet the weak coverage profile means DARE has less flexibility than better-capitalized peers to absorb margin volatility.
Opportunities
The negative cash conversion cycle shows DARE converts supplier terms into operating funding, which can support growth more efficiently than peers with longer cash cycles.
Low days of sales outstanding suggests relatively effective receivables collection, improving liquidity conversion versus peers with slower customer payment profiles.
Net debt to EBITDA remains modest, giving DARE more balance-sheet room than highly levered peers if demand improves and operating cash flow strengthens.
If working-capital discipline persists, the company can preserve liquidity and fund incremental growth with less external capital than peers facing tighter cash needs.
Overall Score
DARE’s forward positioning is constrained by weak coverage and sub-1.0 liquidity, but efficient working-capital management and modest net leverage provide some peer-relative resilience.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Dare Bioscience, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
